[Multidrug-resistant Pseudomonas aeruginosa T]

Teruo Kirikae1

  • 1Department of Infectious Diseases, Research Institute, National Center for Global Health and Medicine.

Insights

Multidrug-resistant Pseudomonas aeruginosa is a growing threat in Japan, with highly resistant strains producing specific enzymes. An immunochromatographic assay offers a rapid detection method for these problematic bacteria.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Multidrug-resistant (MDR) Pseudomonas aeruginosa strains resistant to carbapenems, fluoroquinolones, and amikacin pose a significant challenge in Japan.
  • Nosocomial outbreaks of MDR P. aeruginosa infections are increasingly problematic in healthcare settings.
  • MDR P. aeruginosa isolates constitute approximately 2.5% of all P. aeruginosa isolates in medical facilities.

Purpose of the Study:

  • To address the challenge of multidrug resistance in P. aeruginosa.
  • To develop a rapid detection method for specific enzyme-producing MDR P. aeruginosa strains.

Main Methods:

  • Characterization of multidrug-resistant P. aeruginosa strains, focusing on antibiotic resistance profiles.
  • Identification of key resistance enzymes, including metallo-beta-lactamase IMP-1 and aminoglycoside 6'-N-acetyltransferase AAC(6')-Iae.
  • Development and validation of an immunochromatographic assay for enzyme detection.

Main Results:

  • Clonal expansion of P. aeruginosa strains with high-level resistance (MICs > 64 microg/mL) was observed in community hospitals.
  • The majority of these highly resistant strains produced metallo-beta-lactamase IMP-1 and aminoglycoside 6'-N-acetyltransferase AAC(6')-Iae.
  • The developed immunochromatographic assay demonstrated ease of use and reliability for detecting these enzyme-producing strains.

Conclusions:

  • The emergence of highly resistant MDR P. aeruginosa strains is a critical issue in Japan.
  • The developed immunochromatographic assay provides a valuable tool for the rapid identification of these specific resistant strains.
  • This assay can aid in infection control and timely management of MDR P. aeruginosa outbreaks.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...